Printer Friendly
The Free Library
14,702,589 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Salix Pharmaceuticals Announces 2Q 2004 Financial Results Conference Call and Webcast.


RALEIGH Raleigh (rôl`ē, räl`ē), city (1990 pop. 207,951), state capital, and seat of Wake co., central N.C.; the site was selected for the capital in 1788, and the city was laid out and inc. 1792. , N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: SLXP) today announced that the company will report second quarter ended June 30, 2004 financial results before the market opens on Monday, August 9, 2004.

The Company will host a conference call at 9:00 a.m. ET, on Monday, August 9, 2004. Interested parties may access the conference call by way of web cast or telephone. The live web cast will be available at http://www.salix.com. The web cast will be archived on the Company's web site through August 15.

The telephone numbers to access the conference call are (800) 946-0782 (U.S. and Canada) or (719) 457-2657 (international.) The access code for the call is 550733. A replay of the call will be available from 12:00 noon ET, August 9, through August 15. The telephone numbers to access the replay of the call are (888) 203-1112 (U.S. and Canada) or (719) 457-0820 (international.) The access code for the replay is 550733.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina For other uses of this name, see Raleigh.
Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County.
, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases gastrointestinal disease,
n an abnormal state or function of the GI system.
. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's 100-member gastroenterology gastroenterology

Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833.
 specialty sales and marketing team. Salix trades on the Nasdaq National Market under the ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
 "SLXP."

For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 27, 2004
Words:260
Previous Article:ProMutual Group Launches Pilot Patient Safety Program; Shoulder Dystocia Procedure Training Course Introduced.
Next Article:StarGen Appoints Corporate Controller; Maria Ottaviano to Head Company's Finance and Accounting Operations.
Topics:



Related Articles
Salix Pharmaceuticals to Host Conference Call.
Salix Pharmaceuticals Announces 3Q2004 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 1Q 2005 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals to Present at William Blair & Company Conference.
Salix Pharmaceuticals Announces 2Q2005 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 3Q2005 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 4Q2005 and FY2005 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 1Q2006 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 2Q2006 Financial Results Conference Call and Webcast.
Salix Pharmaceuticals Announces 3Q2006 Financial Results Conference Call and Webcast.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles